IDEXX Laboratories (IDXX) Revenue — Quarter Ended Sep 30, 2025
Revenue for the quarter was essentially flat compared to the immediately preceding quarter, showing a slight decline. Compared with the same quarter one year earlier, revenue rose markedly.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue for the quarter was essentially flat compared to the immediately preceding quarter, showing a slight decline. Compared with the same quarter one year earlier, revenue rose markedly.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
-0.4%
Change from the immediately preceding quarter.
Year-over-year
+13.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $954.3M | +5.8% |
| Mar 31, 2025 | $998.4M | +3.6% |
| Jun 30, 2025 | $1.1B | +10.6% |
| Sep 30, 2025 | $1.1B | +13.3% |
Revenue performance
Reported revenue moved lower relative to the prior quarter, reflecting a modest sequential decrease. The year-over-year comparison, however, showed a substantial increase.
Quarterly comparison
The slight sequential decline contrasts with the strong growth seen from the same quarter a year ago. Over the trailing twelve months, total revenue has been on an upward trajectory.
What to watch
Monitor whether the sequential revenue trend stabilizes or reverses in the coming quarters given the near-flat movement this period.